Gayer Charles K 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Gayer Charles K
Vice President and CCO
Transactions
- Award
Common Stock
2025-12-17+471,000→ 889,827 total - Award
Emp. Stock Option (Right to Buy)
2025-12-17+986,950→ 986,950 totalExercise: $7.13From: 2026-12-17Exp: 2035-12-17→ Common Stock (986,950 underlying)
Footnotes (2)
- [F1]Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.